Susquehanna International Group (Ireland)’s Orphazyme A/S ORPH Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-49,400	Closed	-$510K	–	66
2020 Q3	$510K	Buy	+49,400	New	+$495K	0.46%	19

Other funds holding ORPH

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group (Ireland)'s ORPH Position: Q4 2020 in Review

Susquehanna International Group (Ireland) sold out of Orphazyme A/S (ORPH) in Q4 2020, closing a stake of 49,400 shares — an estimated $510K sold.

Susquehanna International Group (Ireland) first reported a position in ORPH in Q3 2020 and held it in 1 quarter. The position peaked at $510K in Q3 2020. 5 funds tracked by Wall St. Rank hold ORPH as of Q4 2020.

Susquehanna International Group (Ireland) reported no remaining Orphazyme A/S position as of Q4 2020 after selling out during the quarter.
Susquehanna International Group (Ireland) sold 49,400 Orphazyme A/S shares in Q4 2020, an estimated $510K.
Susquehanna International Group (Ireland) first reported a position in Orphazyme A/S in Q3 2020 and held it in 1 quarter.
Susquehanna International Group (Ireland)'s Orphazyme A/S position peaked at $510K in Q3 2020.
5 funds tracked by Wall St. Rank held Orphazyme A/S as of Q4 2020.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q4 2020, filed 16 Feb 2021.